Tyrosine Kinase Inhibitor for Treatment of Adult Allogeneic Hematopoietic Stem Cell Transplantation Candidate with Philadelphia-Positive Acute Lymphoblastic Leukemia

被引:0
|
作者
Wang, Lu [1 ]
Liu, Dai-Hong [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100082, Peoples R China
关键词
Acute Lymphoblastic Leukemia; Allogeneic; Transplantation; Tyrosine Kinase Inhibitor; TERM-FOLLOW-UP; CYTOGENETIC RESPONSES; HYPER-CVAD; IMATINIB; CHEMOTHERAPY; DASATINIB; SURVIVAL; PHASE-2;
D O I
10.4103/0366-6999.197976
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:127 / 129
页数:3
相关论文
共 50 条
  • [41] NILOTINIB AND DONOR LYMPHOCYTE INFUSION IN THE TREATMENT OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PHALL) RELAPSING AFTER ALLOGENEIC STEM CELL TRANSPLANTATION AND RESISTANT TO IMATINIB
    Tiribelli, M.
    Sperotto, A.
    Candoni, A.
    Simeone, E.
    Buttignol, S.
    Fanin, R.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 430 - 430
  • [42] Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
    Gu, Bin
    Wu, Xiaojin
    Chen, Guanghua
    Ma, Xiao
    Jin, Zhengming
    Tang, Xiaowen
    Han, Yue
    Fu, Chengcheng
    Qiu, Huiying
    Sun, Aining
    Wu, Depei
    [J]. LEUKEMIA RESEARCH, 2017, 59 : 41 - 46
  • [43] Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Teng, Chieh-Lin Jerry
    Yu, Jui-Ting
    Chen, Hung-Chieh
    Hwang, Wen-Li
    [J]. ANNALS OF HEMATOLOGY, 2013, 92 (08) : 1137 - 1139
  • [44] Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Chieh-Lin Jerry Teng
    Jui-Ting Yu
    Hung-Chieh Chen
    Wen-Li Hwang
    [J]. Annals of Hematology, 2013, 92 : 1137 - 1139
  • [45] The Use of Imatinib with Chemotherapy and Allogeneic Hematopoietic Stem Cell Transplantation Improves Survival of Philadelphia Positive Acute Lymphoblastic Leukemia in Adults
    Perez-Nunez, Josefina
    Jimenez-Velasco, Antonio
    Hurst, Katy
    Barrios-Garcia, Manuel
    Moreno, M. J.
    Heiniger Mazo, Ana Isabel
    [J]. BLOOD, 2014, 124 (21)
  • [47] Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options
    Theresa Liu-Dumlao
    Hagop Kantarjian
    Deborah A. Thomas
    Susan O’Brien
    Farhad Ravandi
    [J]. Current Oncology Reports, 2012, 14 : 387 - 394
  • [48] Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options
    Liu-Dumlao, Theresa
    Kantarjian, Hagop
    Thomas, Deborah A.
    O'Brien, Susan
    Ravandi, Farhad
    [J]. CURRENT ONCOLOGY REPORTS, 2012, 14 (05) : 387 - 394
  • [49] Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia-Positive Acute Lymphoblastic Leukemia in Children and Adolescents: A Retrospective Multicenter Study of the Italian Association of Pediatric Hematology and Oncology (AIEOP)
    Fagioli, Franca
    Zecca, Marco
    Rognoni, Carla
    Lanino, Edoardo
    Balduzzi, Adriana
    Berger, Massimo
    Messina, Chiara
    Favre, Claudio
    Rabusin, Marco
    Lo Nigro, Luca
    Masetti, Riccardo
    Prete, Arcangelo
    Locatelli, Franco
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (06) : 852 - 860
  • [50] Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes
    Kebriaei, Partow
    Saliba, Rima
    Rondon, Gabriela
    Chiattone, Alexandre
    Luthra, Rajyalakshmi
    Anderlini, Paolo
    Andersson, Borje
    Shpall, Elizabeth
    Popat, Uday
    Jones, Roy
    Worth, Laura
    Ravandi, Farhad
    Thomas, Deborah
    O'Brien, Susan
    Kantarjian, Hagop
    de Lima, Marcos
    Giralt, Sergio
    Champlin, Richard
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (04) : 584 - 592